• ArthroCare (Austin, Texas) reported the launch of Quantum, a platform for arthroscopic surgery that it said would provide surgeons with “the most advanced technology available to help improve clinical outcomes.” The company also released new versions of its two most popular Coblation wands — Super TurboVac and Super MultiVac — that are now equipped with finger switches and work with the Quantum controller to provide surgeons with more flexibility. The Quantum controller is compatible with all existing Coblation wands. The Quantum controller powers Coblation wands that offer surgeons a variety of angles and electrode configurations to perform arthroscopic surgery in any joint. Arthrocare is a developer of minimally invasive surgical products.

•Collagen Matrix (Franklin Lakes, New Jersey) said it has received FDA clearance of its SynOss synthetic mineral bone graft material intended for use in oral surgical applications involving bone repair. SynOss is an osteoconductive calcium phosphate based bone graft material with an apatite structure similar to that of human bone. Unlike hydroxyapatite materials, SynOss has a carbonate apatite structure which is comparable to the mineralized matrix structure of human bone. The company said the similarity in structure between SynOss and natural bone mineral allows for SynOss’ in vivo resorption and remodeling profile to mimic that of natural bone. Collagen Matrix is a collagen- and mineral-based biomaterials company.